Qualitative rather than quantitative changes are hallmarks of fibroblasts in bleomycin-induced pulmonary fibrosis

American Journal of Pathology

Volumn 183, Issue 3, 2013, Pages 758-773

  Tsukui, Tatsuya ^a,b   Ueha, Satoshi ^a,b   Abe, Jun ^a,b   Hashimoto, Shin Ichi ^a,b   Shichino, Shigeyuki ^a,b   Shimaoka, Takeshi ^a,b   Shand, Francis H W ^c   Arakawa, Yasuka ^a,b   Oshima, Kenshiro ^d   Hattori, Masahira ^d   Inagaki, Yutaka ^b,e   Tomura, Michio ^f   Matsushima, Kouji ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF TOKYO   (Japan)

^e TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA2; GREEN FLUORESCENT PROTEIN; OSTEOPONTIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SEQUENCE; DRUG INDUCED DISEASE; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROGENESIS; FLOW CYTOMETRY; GENE; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG ALVEOLUS WALL; LUNG FIBROSIS; LUNG PARENCHYMA; MOUSE; NONHUMAN; PARABIOSIS; PHENOTYPE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SPP1 GENE; UPREGULATION;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; BLEOMYCIN; BONE MARROW CELLS; CELL PROLIFERATION; COLLAGEN TYPE I; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE ONTOLOGY; GREEN FLUORESCENT PROTEINS; LUNG; MICE; MICE, INBRED C57BL; OSTEOPONTIN; PULMONARY FIBROSIS; RECOMBINANT FUSION PROTEINS; UP-REGULATION;

EID: 84883155635     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.06.005     Document Type: Article

References (54)

1. T.A. Wynn, and T.R. Ramalingam Mechanisms of fibrosis: therapeutic translation for fibrotic disease Nat Med 18 2012 1028 1040
2. T.E. King Jr., A. Pardo, and M. Selman Idiopathic pulmonary fibrosis Lancet 378 2011 1949 1961
3. T.A. Wynn Cellular and molecular mechanisms of fibrosis J Pathol 214 2008 199 210
4. B. Hinz, S.H. Phan, V.J. Thannickal, A. Galli, M.L. Bochaton-Piallat, and G. Gabbiani The myofibroblast Am J Pathol 170 2007 1807 1816
5. T.A. Wynn Integrating mechanisms of pulmonary fibrosis J Exp Med 208 2011 1339 1350
6. P.W. Noble, C.E. Barkauskas, and D. Jiang Pulmonary fibrosis: patterns and perpetrators J Clin Invest 122 2012 2756 2762
7. K.K. Kim, Y. Wei, C. Szekeres, M.C. Kugler, P.J. Wolters, M.L. Hill, J.A. Frank, A.N. Brumwell, S.E. Wheeler, J.A. Kreidberg, and H.A. Chapman Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis J Clin Invest 119 2009 213 224
8. H. Tanjore, X.C. Xu, V.V. Polosukhin, A.L. Degryse, B. Li, W. Han, T.P. Sherrill, D. Plieth, E.G. Neilson, T.S. Blackwell, and W.E. Lawson Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis Am J Respir Crit Care Med 180 2009 657 665
9. R.K. Hoyles, E.C. Derrett-Smith, K. Khan, X. Shiwen, S.L. Howat, A.U. Wells, D.J. Abraham, and C.P. Denton An essential role for resident fibroblasts in experimental lung fibrosis is defined by lineage-specific deletion of high-affinity type II transforming growth factor receptor Am J Respir Crit Care Med 183 2010 249 261
10. J.R. Rock, C.E. Barkauskas, M.J. Cronce, Y. Xue, J.R. Harris, J. Liang, P.W. Noble, and B.L.M. Hogan Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition Proc Natl Acad Sci USA 108 2011 E1475 E1483
11. S.L. Lin, T. Kisseleva, D.A. Brenner, and J.S. Duffield Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney Am J Pathol 173 2008 1617 1627
12. C. Göritz, D.O. Dias, N. Tomilin, M. Barbacid, O. Shupliakov, and J. Frisén A pericyte origin of spinal cord scar tissue Science 333 2011 238 242
13. E.L. Herzog, A.R. Brody, T.V. Colby, R. Mason, and M.C. Williams Knowns and unknowns of the alveolus Proc Am Thorac Soc 5 2008 778 782
14. L.A. Kunz-Schughart, S. Wenninger, T. Neumeier, P. Seidl, and R. Knuechel Three-dimensional tissue structure affects sensitivity of fibroblasts to TGF-beta 1 Am J Physiol Cell Physiol 284 2003 C209 C219
15. S. De Val, M. Ponticos, T.T. Antoniv, D.J. Wells, D. Abraham, T. Partridge, and G. Bou-Gharios Identification of the key regions within the mouse pro-alpha 2(I) collagen gene far-upstream enhancer J Biol Chem 277 2001 9286 9292
16. R. Higashiyama, T. Moro, S. Nakao, K. Mikami, H. Fukumitsu, Y. Ueda, K. Ikeda, E. Adachi, G. Bou-Gharios, I. Okazaki, and Y. Inagaki Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice Gastroenterology 137 2009 1459 1466
17. M. Tomura, Y.S. Mori, R. Watanabe, M. Tanaka, A. Miyawaki, and O. Kanagawa Time-lapse observation of cellular function with fluorescent probe reveals novel CTL-target cell interactions Int Immunol 21 2009 1145 1150
18. W.M. Foster, D.M. Walters, M. Longphre, K. Macri, and L.M. Miller Methodology for the measurement of mucociliary function in the mouse by scintigraphy J Appl Physiol 90 2001 1111 1117
19. C. Shimbori, N. Shiota, and H. Okunishi Involvement of leukotrienes in the pathogenesis of silica-induced pulmonary fibrosis in mice [Erratum appeared in Exp Lung Res 2010, 36:440] Exp Lung Res 36 2010 292 301
20. M. Fujita, J.M. Shannon, C.G. Irvin, K.A. Fagan, C. Cool, A. Augustin, and R.J. Mason Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension Am J Physiol Lung Cell Mol Physiol 280 2001 L39 L49
21. D.W. Huang, B.T. Sherman, and R.A. Lempicki Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat Protoc 4 2008 44 57
22. Y. Kapanci, C. Ribaux, C. Chaponnier, and G. Gabbiani Cytoskeletal features of alveolar myofibroblasts and pericytes in normal human and rat lung J Histochem Cytochem 40 1992 1955 1963
23. Y. Fukuda, V.J. Ferrans, C.I. Schoenberger, S.I. Rennard, and R.G. Crystal Patterns of pulmonary structural remodeling after experimental paraquat toxicity. The morphogenesis of intraalveolar fibrosis Am J Pathol 118 1985 452 475
24. M. Kawamoto, and Y. Fukuda Cell proliferation during the process of bleomycin-induced pulmonary fibrosis in rats Acta Pathol Jpn 40 1990 227 238
25. P.L. Moseley, C. Hemken, and G.W. Hunninghake Augmentation of fibroblast proliferation by bleomycin J Clin Invest 78 1986 1150 1154
26. T. Mio, S. Nagai, M. Kitaichi, A. Kawatani, and T. Izumi Proliferative characteristics of fibroblast lines derived from open lung biopsy specimens of patients with IPF (UIP) Chest 102 1992 832 837
27. E.M. Messier, R.J. Mason, and B. Kosmider Efficient and rapid isolation and purification of mouse alveolar type II epithelial cells Exp Lung Res 38 2012 363 373
28. M.A. Mouratis, and V. Aidinis Modeling pulmonary fibrosis with bleomycin Curr Opin Pulm Med 17 2011 355 361
29. K. Zhang, M.D. Rekhter, D. Gordon, and S.H. Phan Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study Am J Pathol 145 1994 114 125
30. K. Takemoto Spatio-temporal activation of caspase revealed by indicator that is insensitive to environmental effects J Cell Biol 160 2003 235 243
31. T. Nagai, and A. Miyawaki A high-throughput method for development of FRET-based indicators for proteolysis Biochem Biophys Res Commun 319 2004 72 77
32. A. Sakaue-Sawano, H. Kurokawa, T. Morimura, A. Hanyu, H. Hama, H. Osawa, S. Kashiwagi, K. Fukami, T. Miyata, H. Miyoshi, T. Imamura, M. Ogawa, H. Masai, and A. Miyawaki Visualizing spatiotemporal dynamics of multicellular cell-cycle progression Cell 132 2008 487 498
33. R.J. Phillips, M.D. Burdick, K. Hong, M.A. Lutz, L.A. Murray, Y.Y. Xue, J.A. Belperio, M.P. Keane, and R.M. Strieter Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis J Clin Invest 114 2004 438 446
34. N. Hashimoto Bone marrow-derived progenitor cells in pulmonary fibrosis J Clin Invest 113 2004 243 252
35. A. Pardo, K. Gibson, J. Cisneros, T.J. Richards, Y. Yang, C. Becerril, S. Yousem, I. Herrera, V. Ruiz, M. Selman, and N. Kaminski Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis PLoS Med 2 2005 e251
36. N. Kaminski, J.D. Allard, J.F. Pittet, F. Zuo, M.J. Griffiths, D. Morris, X. Huang, D. Sheppard, and R.A. Heller Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis Proc Natl Acad Sci USA 97 2000 1778 1783
37. D.J. Kass, G. Yu, K.S. Loh, A. Savir, A. Borczuk, R. Kahloon, B. Juan-Guardela, G. Deiuliis, J. Tedrow, J. Choi, T. Richards, N. Kaminski, and S.M. Greenberg Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs Am J Pathol 180 2012 1963 1978
38. N. Oikonomou, A. Thanasopoulou, A. Tzouvelekis, V. Harokopos, T. Paparountas, I. Nikitopoulou, W. Witke, A. Karameris, A. Kotanidou, D. Bouros, and V. Aidinis Gelsolin expression is necessary for the development of modelled pulmonary inflammation and fibrosis Thorax 64 2009 467 475
39. Y. Zhou, K. Koli, J.S. Hagood, M. Miao, M. Mavalli, D.B. Rifkin, and J.E. Murphy-Ullrich Latent transforming growth factor-β-binding protein-4 regulates transforming growth factor-β1 bioavailability for activation by fibrogenic lung fibroblasts in response to bleomycin Am J Pathol 174 2009 21 33
40. Y. Ishii Gefitinib prevents bleomycin-induced lung fibrosis in mice Am J Respir Crit Care Med 174 2006 550 556
41. M.S. Wilson, S.K. Madala, T.R. Ramalingam, B.R. Gochuico, I.O. Rosas, A.W. Cheever, and T.A. Wynn Bleomycin and IL-1-mediated pulmonary fibrosis is IL-17A dependent J Exp Med 207 2010 535 552
42. J.S. Berman Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice Am J Physiol Lung Cell Mol Physiol 286 2004 L1311 L1318
43. C. Ramos, M. Montaño, J. García-Alvarez, V. Ruiz, B.D. Uhal, M. Selman, and A. Pardo Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression Am J Respir Cell Mol Biol 24 2001 591 598
44. B.D. Humphreys, S.L. Lin, A. Kobayashi, T.E. Hudson, B.T. Nowlin, J.V. Bonventre, M.T. Valerius, A.P. McMahon, and J.S. Duffield Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis Am J Pathol 176 2010 85 97
45. J.I. Virag, and C.E. Murry Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair Am J Pathol 163 2003 2433 2440
46. H. Xia, R. Nho, J. Kleidon, J. Kahm, and C.A. Henke Polymerized collagen inhibits fibroblast proliferation via a mechanism involving the formation of a beta1 integrin-protein phosphatase 2A-tuberous sclerosis complex 2 complex that suppresses S6K1 activity J Biol Chem 283 2008 20350 20360
47. P.W. Noble Back to the future: historical perspective on the pathogenesis of idiopathic pulmonary fibrosis Am J Respir Cell Mol Biol 33 2005 113 120
48. J. Myers, and A. Katzenstein Epithelial necrosis and alveolar collapse in the pathogenesis of usual interstitial pneumonia Chest 94 1988 1309 1311
49. T. Uede Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases Pathol Int 61 2011 265 280
50. R. Mori, T.J. Shaw, and P. Martin Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring J Exp Med 205 2008 43 51
51. Y. Lenga, A. Koh, A.S. Perera, C.A. McCulloch, J. Sodek, and R. Zohar Osteopontin expression is required for myofibroblast differentiation Circ Res 102 2008 319 327
52. D.M. Serlin, P.P. Kuang, M. Subramanian, A. O'Regan, X. Li, J.S. Berman, and R.H. Goldstein Interleukin-1β induces osteopontin expression in pulmonary fibroblasts J Cell Biochem 97 2006 519 529
53. A. Anwar, M. Li, M.G. Frid, B. Kumar, E.V. Gerasimovskaya, S.R. Riddle, B.A. McKeon, R. Thukaram, B.O. Meyrick, M.A. Fini, and K.R. Stenmark Osteopontin is an endogenous modulator of the constitutively activated phenotype of pulmonary adventitial fibroblasts in hypoxic pulmonary hypertension Am J Physiol Lung Cell Mol Physiol 303 2012 L1 L11
54. R. Higashiyama, S. Nakao, Y. Shibusawa, O. Ishikawa, T. Moro, K. Mikami, H. Fukumitsu, Y. Ueda, K. Minakawa, Y. Tabata, G. Bou-Gharios, and Y. Inagaki Differential contribution of dermal resident and bone marrow-derived cells to collagen production during wound healing and fibrogenesis in mice J Invest Dermatol 131 2011 529 536